Compare GDDY & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDDY | FMS |
|---|---|---|
| Founded | 1997 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | EDP Services | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 13.9B |
| IPO Year | 2015 | 1996 |
| Metric | GDDY | FMS |
|---|---|---|
| Price | $90.86 | $24.06 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 15 | 2 |
| Target Price | ★ $177.40 | $30.00 |
| AVG Volume (30 Days) | ★ 1.8M | 797.2K |
| Earning Date | 02-24-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 2.37% |
| EPS Growth | N/A | ★ 8.62 |
| EPS | ★ 5.80 | 2.86 |
| Revenue | $4,869,800,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $10.29 | $2.13 |
| Revenue Next Year | $6.90 | $2.95 |
| P/E Ratio | $16.57 | ★ $15.75 |
| Revenue Growth | ★ 8.68 | 2.10 |
| 52 Week Low | $92.22 | $20.95 |
| 52 Week High | $213.87 | $30.46 |
| Indicator | GDDY | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 23.65 | 60.09 |
| Support Level | $92.22 | $23.46 |
| Resistance Level | $98.81 | $24.15 |
| Average True Range (ATR) | 3.50 | 0.38 |
| MACD | -0.05 | 0.24 |
| Stochastic Oscillator | 2.75 | 89.05 |
GoDaddy provides a comprehensive portfolio of solutions to help entrepreneurs manage their company's digital presence. In particular, GoDaddy helps customers establish websites, attract customers, and generate revenue. It operates through two segments—the core platform and applications and commerce. The core platform consists of domain registration services as well as hosting and security services. The newer applications and commerce segment consists of website design, marketing tools, and payment services. As of fiscal 2024, the company had over 20,000 customers and greater than 80 million domains under management.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.